Eiger BioPharmaceuticals Inc
OTC:EIGRQ

Watchlist Manager
Eiger BioPharmaceuticals Inc Logo
Eiger BioPharmaceuticals Inc
OTC:EIGRQ
Watchlist
Price: 8.5 USD Market Closed
Market Cap: 12.6m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of EIGRQ.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EIGRQ Intrinsic Value
Not Available
Base Case Scenario
Compare EIGRQ to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EIGRQ?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eiger BioPharmaceuticals Inc

Current Assets 37.8m
Cash & Short-Term Investments 25.4m
Receivables 1.7m
Other Current Assets 10.7m
Non-Current Assets 987k
PP&E 627k
Other Non-Current Assets 360k
Current Liabilities 53.3m
Accounts Payable 2.1m
Accrued Liabilities 10.1m
Other Current Liabilities 41.1m
Efficiency

Free Cash Flow Analysis
Eiger BioPharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eiger BioPharmaceuticals Inc

Revenue
15.8m USD
Cost of Revenue
-16k USD
Gross Profit
15.8m USD
Operating Expenses
-87.5m USD
Operating Income
-71.8m USD
Other Expenses
-3.2m USD
Net Income
-75m USD
Fundamental Scores

EIGRQ Profitability Score
Profitability Due Diligence

Eiger BioPharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Net Margin is Increasing
hidden
Profitability
Score

Eiger BioPharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

EIGRQ Solvency Score
Solvency Due Diligence

Eiger BioPharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Eiger BioPharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EIGRQ Price Targets Summary
Eiger BioPharmaceuticals Inc

There are no price targets for EIGRQ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Eiger BioPharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EIGRQ is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y